FDA Authorizes a COVID-19 Diagnostic Test for Asymptomatic Individuals

One of the challenges in controlling the rate of new infections during the COVID-19 pandemic has been the lack of a diagnostic test specifically indicated for asymptomatic patients. According to some estimates, nearly 40% of the new cases of SARS-CoV-2 infections do not have any visible symptoms. As a result, many of those infected are not aware they are carrying the virus and may be inadvertently adding to the rising rates of new infections. A newly authorized diagnostic test for asymptomatic patients could help.

Regulatory News, Industry NewsNaveen AgarwalAugust 3, 2020COVID-19, covid-19, asymptomatic, diagnostic testing, diagnosis, FDA regulation, FDA News, FDA authorization, coronavirus crisis, coronavirus, FDA approves coronavirus tests, FDA approvalComment